AAAAAA

   
Results: 1-25 |
Results: 25

Authors: ROSNER AJ GRIMA DT TORRANCE GW BRADLEY C ADACHI JD SEBALDT RJ WILLISON DJ
Citation: Aj. Rosner et al., COST-EFFECTIVENESS OF MULTI-THERAPY TREATMENT STRATEGIES IN THE PREVENTION OF VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, PharmacoEconomics, 14(5), 1998, pp. 559-573

Authors: TORRANCE GW FEENY D GOLDSMITH C FURLONG W ZHU Z DEPAUW S
Citation: Gw. Torrance et al., A MULTILINEAR MULTIATTRIBUTE UTILITY FUNCTION FOR THE HEALTH-UTILITIES-INDEX-MARK-3 (HUI3), Medical decision making, 18(4), 1998, pp. 490-490

Authors: OBRIEN BJ GOEREE R GAFNI A TORRANCE GW PAULY MV ERDER H RUSTHOVEN J WEEKS J CAHILL M LAMONT B
Citation: Bj. Obrien et al., ASSESSING THE VALUE OF A NEW PHARMACEUTICAL - A FEASIBILITY STUDY OF CONTINGENT VALUATION IN MANAGED CARE, Medical care, 36(3), 1998, pp. 370-384

Authors: SIEGEL JE TORRANCE GW RUSSELL LB LUCE BR WEINSTEIN MC GOLD MR
Citation: Je. Siegel et al., GUIDELINES FOR PHARMACOECONOMIC STUDIES - RECOMMENDATIONS FROM THE PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE, PharmacoEconomics, 11(2), 1997, pp. 159-168

Authors: TORRANCE GW
Citation: Gw. Torrance, PREFERENCES FOR HEALTH OUTCOMES AND COST-UTILITY ANALYSIS, American journal of managed care, 3, 1997, pp. 8-20

Authors: WEINSTEIN MC SIEGEL JE GARBER AM LIPSCOMB J LUCE BR MANNING WG TORRANCE GW
Citation: Mc. Weinstein et al., PRODUCTIVITY COSTS, TIME COSTS AND HEALTH-RELATED QUALITY-OF-LIFE - ARESPONSE TO THE ERASMUS GROUP, Health economics, 6(5), 1997, pp. 505-510

Authors: BENNETT KJ TORRANCE GW MORAN LA SMITH F GOLDSMITH CH
Citation: Kj. Bennett et al., HEALTH STATE UTILITIES IN KNEE REPLACEMENT SURGERY - THE DEVELOPMENT AND EVALUATION OF MCKNEE, Journal of rheumatology, 24(9), 1997, pp. 1796-1805

Authors: SIEGEL JE WEINSTEIN MC FRYBACK DG MANNING WG TORRANCE GW RUSSELL LB GOLD MR
Citation: Je. Siegel et al., REPORTING COST-EFFECTIVENESS ANALYSES WITH CONFIDENCE - REPLY, JAMA, the journal of the American Medical Association, 277(5), 1997, pp. 375-375

Authors: FRYBACK DG SIEGEL JE MANNING WG TORRANCE GW RUSSELL LB PATRICK DL
Citation: Dg. Fryback et al., THE NEGATIVE SIDE OF COST-EFFECTIVENESS ANALYSIS - REPLY, JAMA, the journal of the American Medical Association, 277(24), 1997, pp. 1933-1933

Authors: TORRANCE GW BLAKER D DETSKY A KENNEDY W SCHUBERT F MENON D TUGWELL P KONCHAK R HUBBARD E FIRESTONE T
Citation: Gw. Torrance et al., CANADIAN GUIDELINES FOR ECONOMIC-EVALUATION OF PHARMACEUTICALS, PharmacoEconomics, 9(6), 1996, pp. 535-559

Authors: BARR RD FURLONG W HORSMAN JR FEENY D TORRANCE GW WEITZMAN S
Citation: Rd. Barr et al., THE MONETARY COSTS OF CHILDHOOD-CANCER TO THE FAMILIES OF PATIENTS, International journal of oncology, 8(5), 1996, pp. 933-940

Authors: TORRANCE GW FEENY DH FURLONG WJ BARR RD ZHANG YM WANG QN
Citation: Gw. Torrance et al., MULTIATTRIBUTE UTILITY FUNCTION FOR A COMPREHENSIVE HEALTH-STATUS CLASSIFICATION-SYSTEM - HEALTH-UTILITIES-INDEX-MARK-2, Medical care, 34(7), 1996, pp. 702-722

Authors: MENON D SCHUBERT F TORRANCE GW
Citation: D. Menon et al., CANADA NEW GUIDELINES FOR THE ECONOMIC-EVALUATION OF PHARMACEUTICALS, Medical care, 34(12), 1996, pp. 77-86

Authors: FEENY D FURLONG W BOYLE M TORRANCE GW
Citation: D. Feeny et al., MULTIATTRIBUTE HEALTH-STATUS CLASSIFICATION SYSTEMS - HEALTH UTILITIES INDEX, PharmacoEconomics, 7(6), 1995, pp. 490-502

Authors: TORRANCE GW FURLONG W FEENY D BOYLE M
Citation: Gw. Torrance et al., MULTIATTRIBUTE PREFERENCE FUNCTIONS - HEALTH UTILITIES INDEX, PharmacoEconomics, 7(6), 1995, pp. 503-520

Authors: BARR RD FEENY D FURLONG W WEITZMAN S TORRANCE GW
Citation: Rd. Barr et al., A PREFERENCE-BASED APPROACH TO HEALTH-RELATED QUALITY-OF-LIFE FOR CHILDREN WITH CANCER, International journal of pediatric hematology/oncology, 2(4), 1995, pp. 305-315

Authors: BOYLE MH FURLONG W FEENY D TORRANCE GW HATCHER J
Citation: Mh. Boyle et al., RELIABILITY OF THE HEALTH UTILITIES INDEX - MARK-III USED IN THE 1991CYCLE-6 CANADIAN GENERAL SOCIAL SURVEY HEALTH QUESTIONNAIRE, Quality of life research, 4(3), 1995, pp. 249-257

Authors: HART LE GOLDSMITH CH TORRANCE GW ANDERSON C MARKHAM B BENNETT K CHURCHILL EJ TUGWELL P
Citation: Le. Hart et al., A RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECTIVENESS OF A RHEUMATOLOGY DAY HOSPITAL PROGRAM, Arthritis and rheumatism, 38(9), 1995, pp. 1371-1371

Authors: BARR RD PAI MKR WEITZMAN S FEENY D FURLONG W ROSENBAUM P TORRANCE GW
Citation: Rd. Barr et al., A MULTIATTRIBUTE APPROACH TO HEALTH-STATUS MEASUREMENT AND CLINICAL MANAGEMENT ILLUSTRATED BY AN APPLICATION TO BRAIN-TUMORS IN CHILDHOOD, International journal of oncology, 4(3), 1994, pp. 639-648

Authors: FURLONG W TORRANCE GW FEENY D BOYLE M
Citation: W. Furlong et al., MCMASTER HEALTH UTILITIES INDEX OF HEALTH-RELATED QUALITY-OF-LIFE, Quality of life research, 3(1), 1994, pp. 76-77

Authors: SAIGAL S FURLONG W FEENY D ROSENBAUM P TORRANCE GW
Citation: S. Saigal et al., HEALTH-RELATED QUALITY-OF-LIFE OF EXTREMELY LOW-BIRTH-WEIGHT CHILDRENAND CONTROLS AT AGE 8 YEARS, Quality of life research, 3(1), 1994, pp. 92-92

Authors: SAIGAL S ROSENBAUM PL FURLONG WJ FEENY DH TORRANCE GW
Citation: S. Saigal et al., A COMPREHENSIVE ASSESSMENT OF THE HEALTH-STATUS OF EXTREMELY LOW-BIRTH-WEIGHT CHILDREN (LESS-THAN-1000G BW) AND CONTROLS AT 8 YEARS OF AGE, Pediatric research, 35(2), 1994, pp. 264-264

Authors: REYNOLDS DL TORRANCE GW BADLEY EM BENNETT KJ CHAMBERS LW GOLDSMITH CH JAMIESON E TUGWELL P WOLFSON MC
Citation: Dl. Reynolds et al., MODELING THE POPULATION HEALTH IMPACT OF MUSCULOSKELETAL DISEASES - ARTHRITIS, Journal of rheumatology, 20(6), 1993, pp. 1037-1047

Authors: RIEDEMANN PJ BERSINIC S CUDDY LJ TORRANCE GW TUGWELL PX
Citation: Pj. Riedemann et al., A STUDY TO DETERMINE THE EFFICACY AND SAFETY OF TENOXICAM VERSUS PIROXICAM, DICLOFENAC AND INDOMETHACIN IN PATIENTS WITH OSTEOARTHRITIS - AMETAANALYSIS, Journal of rheumatology, 20(12), 1993, pp. 2095-2103

Authors: FEENY D LEIPER A BARR RD FURLONG W TORRANCE GW ROSENBAUM P WEITZMAN S
Citation: D. Feeny et al., THE COMPREHENSIVE ASSESSMENT OF HEALTH-STATUS IN SURVIVORS OF CHILDHOOD-CANCER - APPLICATION TO HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Cancer, 67(5), 1993, pp. 1047-1052
Risultati: 1-25 |